CMC Considerations for Developing an Effective mRNA/LNP Therapeutic

Поділитися
Вставка
  • Опубліковано 21 лип 2024
  • Dr. Akhilesh Bhambhani, Sr. Director of Biologics Drug Product Development at Ultragenyx discusses CMC Considerations for developing an effective mRNA/LNP therapeutic.
    Learn more about microfluidic technology: www.precisionnanosystems.com/...
    Follow us on LinkedIn: bit.ly/3F9uEiL
    Follow us on Twitter: bit.ly/3yBttpW
  • Наука та технологія

КОМЕНТАРІ •